Cancer immunology and immunotherapy

Open Access
Organoid models in oncology: advancing precision cancer therapy and vaccine development
Yuxuan Xiao, Yutao Li, Xilin Jing, Lin Weng, Xu Liu, Qingyun Liu and Kezhong Chen

Cancer Biology & Medicine August 2025, 22 (8) 903-927; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0127
Open Access
Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy
Zhiqiang Shi, Qiuchen Zhao, Yongsheng Wang and Pengfei Qiu

Cancer Biology & Medicine July 2025, 22 (7) 722-725; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0251
Open Access
Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies
Ziyou Lin, Chang Chang, Shuyu Zhao, Lan Fang and Ping Wang

Cancer Biology & Medicine July 2025, 22 (7) 726-746; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0115
Open Access
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang and Jinxiu Shi

Cancer Biology & Medicine July 2025, 22 (7) 854-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0038
Open Access
Neutrophils in cancer: from immune defense to tumor promotion
Zhen Wang, Hanwen Hu, Yunjia Bao, Liwei Pang and Chenghui Yang

Cancer Biology & Medicine June 2025, 22 (6) 598-617; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0023
Open Access
Malignant ascites enhance γδ T cell cytotoxicity toward ovarian cancer via chemokine-mediated recruitment
Zhanqun Yang, Ying Liu, Mengzhu Zheng, Hui Li, Ruoyao Cui, Pan Wang, Tianhui He, Hongyan Guo, Yinglin Zhou, Jian Lin and Long Chen

Cancer Biology & Medicine June 2025, 22 (6) 639-643; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0072
Open Access
Increased and persistent absolute CD4+ T cell count in an HIV-associated Burkitt lymphoma patient with central nervous system involvement after axicabtagene ciloleucel therapy
Yao Qi, Jia Wang, Jingyi Li and Qi Deng

Cancer Biology & Medicine June 2025, 22 (6) 644-647; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0087
Open Access
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity
Shumeng Lin, Liuliu Yuan, Xiao Chen, Shiyin Chen, Mengling Wei, Bingjie Hao, Tiansheng Zheng and Lihong Fan

Cancer Biology & Medicine June 2025, 22 (6) 648-671; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0596
Open Access
The mechanisms and clinical significance of CD8⁺ T cell exhaustion in anti-tumor immunity
Tao Zhong, Shuo Sun, Mingsheng Zhao, Bin Zhang and Huabao Xiong

Cancer Biology & Medicine May 2025, 22 (5) 460-480; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0628
Open Access
CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy
Hui Luo, Tongjuan Li, Fankai Meng, Zhenya Hong, Yang Cao, Gaoxiang Wang, Liang Huang and Xiaoxi Zhou

Cancer Biology & Medicine May 2025, 22 (5) 496-501; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0626

Main menu

User menu

Search

Cancer immunology and immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services